Posted:
5/11/2026, 6:43:15 AM
Location(s):
Somerville, Massachusetts, United States ⋅ Massachusetts, United States
Experience Level(s):
Mid Level ⋅ Senior
Field(s):
Medical, Clinical & Veterinary
Workplace Type:
Hybrid
The Role:
We are seeking a Principal Scientist, DS Process Development & Manufacturing, to join our growing Drug Substance group at Generate:Biomedicines. This role will support monoclonal antibody (mAb) drug substance development with a strong MS&T focus, bridging process development, scale-up, tech transfer, and GMP manufacturing execution. The position offers broad exposure across upstream and downstream operations, CDMO management, and quality systems.
Here's how you will contribute:
The Ideal Candidate will have:
Nice to Have (Optional)
Location: This role is based out of Somerville, MA with flexibility for hybrid work (1-2 days a week in the office).
Why Join Us?
This is an opportunity to contribute to the development of innovative biologics at a company transforming medicine through Generative Biology™. At Generate Biomedicines, you’ll work closely with cross-functional teams and external partners to support the delivery of high-quality Drug Substance for clinical programs. You’ll gain or broaden your exposure to late-stage CMC activities, collaborate with leading CDMOs, and play a key role in ensuring robust documentation and data integrity for products that matter to patients.
About Generate Biomedicines
We are a clinical-stage generative biology company pioneering the AI revolution in drug design and development. We are advancing a new approach to drug creation—one grounded in the ability to design proteins with defined biological intent. By integrating machine learning with large-scale experimentation, this approach aims to reduce the uncertainty, time, and cost associated with developing protein-based medicines.
Founded in 2018, we are advancing a growing pipeline of clinical and preclinical programs across multiple disease areas and protein modalities. By unifying computational design and clinical development within a single operating model, we translate this approach into clinical-stage programs and are leading a shift from traditional drug discovery toward systematic drug generation.
At Generate:Biomedicines, we collaborate across disciplines in new ways to invent and innovate. We bring diverse perspectives to a shared goal of delivering better medicines to patients in need, faster, guided by our values and leadership behaviors.
Generate:Biomedicines is committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies: Generate:Biomedicines does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Generate:Biomedicines or its employees is strictly prohibited unless contacted directly by the Company’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Generate:Biomedicines and the Company will not owe any referral or other fees with respect thereto.
#LI-RT1
Compensation: The base salary range provided reflects our current estimate of what we anticipate paying for this position. Your actual base salary will be based on several factors, including job-related skills, experience, internal equity, relevant education or training, and market dynamics. In addition, you will be eligible for an annual bonus, equity compensation, and a competitive benefits package.
Website: https://generatebiomedicines.com/
Headquarter Location: Somerville, Massachusetts, United States
Employee Count: 251-500
Year Founded: 2018
IPO Status: Private
Last Funding Type: Series C
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Product Research